| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 562 | 2018 |
| Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial CA Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, G Salles, ... The lancet oncology 23 (1), 91-103, 2022 | 433 | 2022 |
| Hyposplenism: a comprehensive review. Part I: basic concepts and causes BM William, GR Corazza Hematology 12 (1), 1-13, 2007 | 231 | 2007 |
| Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management BM William, N Thawani, S Sae-Tia, GR Corazza Hematology 12 (2), 89-98, 2007 | 158 | 2007 |
| Autologous transplantation in follicular lymphoma with early therapy failure: a National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis C Casulo, JW Friedberg, KW Ahn, C Flowers, A DiGilio, SM Smith, ... Biology of blood and marrow transplantation 24 (6), 1163-1171, 2018 | 154 | 2018 |
| CC-486 maintenance after stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndromes M De Lima, B Oran, RE Champlin, EB Papadopoulos, SA Giralt, BL Scott, ... Biology of Blood and Marrow Transplantation 24 (10), 2017-2024, 2018 | 151 | 2018 |
| Primary analysis of Zuma-5: a phase 2 study of axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) C Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, G Salles, ... Blood 136, 40-41, 2020 | 144 | 2020 |
| IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label … M Bagot, P Porcu, A Marie-Cardine, M Battistella, BM William, M Vermeer, ... The Lancet Oncology 20 (8), 1160-1170, 2019 | 139 | 2019 |
| International analysis of the frequency and outcomes of NK/T-cell lymphomas BM William, JO Armitage Best Practice & Research Clinical Haematology 26 (1), 23-32, 2013 | 100 | 2013 |
| NCCN guidelines insights: primary cutaneous lymphomas, version 2.2020: featured updates to the NCCN guidelines N Mehta-Shah, SM Horwitz, S Ansell, WZ Ai, J Barnes, SK Barta, ... Journal of the National Comprehensive Cancer Network 18 (5), 522-536, 2020 | 93 | 2020 |
| An LC–MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial SR Kunati, S Yang, BM William, Y Xu Journal of pharmaceutical and biomedical analysis 156, 189-198, 2018 | 84 | 2018 |
| Scoring system prognostic of outcome in patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome BC Shaffer, KW Ahn, ZH Hu, T Nishihori, AK Malone, D Valcárcel, ... Journal of Clinical Oncology 34 (16), 1864-1871, 2016 | 81 | 2016 |
| Pharmacology and molecular mechanisms of antineoplastic agents for hematologic malignancies SL Gerson, PF Caimi, BM William, RJ Creger Hematology: basic principles and practice, 849-912, 2018 | 70 | 2018 |
| Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome AS Kittai, DA Bond, B William, A Saad, S Penza, Y Efebera, K Larkin, ... Blood Advances 4 (19), 4648-4652, 2020 | 67 | 2020 |
| Interim analysis of ZUMA-5: A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed/refractory indolent non-Hodgkin lymphoma (R/R iNHL). CA Jacobson, JC Chavez, AR Sehgal, BM William, J Munoz, GA Salles, ... Journal of Clinical Oncology 38 (15_suppl), 8008-8008, 2020 | 67 | 2020 |
| Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma T Radivoyevitch, RM Dean, BE Shaw, R Brazauskas, HR Tecca, ... Leukemia research 74, 130-136, 2018 | 63 | 2018 |
| NCCN guidelines insights: T-cell lymphomas, version 2.2018 SM Horwitz, SM Ansell, WZ Ai, J Barnes, SK Barta, M Choi, MW Clemens, ... Journal of the National Comprehensive Cancer Network 16 (2), 123-135, 2018 | 61 | 2018 |
| Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: a center for international blood and marrow transplant research analysis A Mahindra, P Hari, R Fraser, M Fei, J Huang, J Berdeja, N Callander, ... Bone marrow transplantation 52 (12), 1616-1622, 2017 | 61 | 2017 |
| Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD SA Wall, Q Zhao, M Yearsley, L Blower, A Agyeman, P Ranganathan, ... Blood advances 2 (20), 2619-2628, 2018 | 56 | 2018 |
| Bortezomib for the treatment of mantle cell lymphoma: an update B Hambley, PF Caimi, BM William Therapeutic advances in hematology 7 (4), 196-208, 2016 | 56 | 2016 |